MilliporeSigma

TP53 and outcome in DLBCL: not only the coding region.

Blood (2013-06-01)
Fabrice Jardin, Bertrand Coiffier
ABSTRACT

In this issue of Blood, Li et al report mutations in the 3′ untranslated region (3′UTR) of TP53 that modify the expression of p53 and thus its effect on response to therapy in diffuse large B-cell lymphoma (DLBCL) patients.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Cyclophosphamide monohydrate, ISOPAC®
Sigma-Aldrich
Cyclophosphamide monohydrate, bulk package
Sigma-Aldrich
Vincristine sulfate salt, 95.0-105.0% (HPLC), powder or crystals
Sigma-Aldrich
Doxorubicin hydrochloride, suitable for fluorescence, 98.0-102.0% (HPLC)
Sigma-Aldrich
Vincristine sulfate, meets USP testing specifications
Sigma-Aldrich
Prednisone, ≥98%
Sigma-Aldrich
Doxorubicin hydrochloride, 98.0-102.0% (HPLC)
Supelco
Prednisone, Pharmaceutical Secondary Standard; Certified Reference Material
Vincristine sulfate, European Pharmacopoeia (EP) Reference Standard
Doxorubicin hydrochloride, European Pharmacopoeia (EP) Reference Standard